|
Market Closed -
Nasdaq
16:00:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 3.490 USD | +2.65% |
|
+25.99% | -72.63% |
| 10-28 | Scienture Holdings, Inc. - Shareholder/Analyst Call | |
| 10-13 | Scienture Holdings, Inc. Reports Preliminary, Unaudited Revenue Results for the Third Quarter Ended September 30, 2026 | CI |
| Market Cap | 5.73M 5.13M 4.74M 4.29M 8.02M 546M 8.15M 56.51M 22.55M 286M 21.51M 21.06M 905M | P/E 2026 * |
-0.79x | P/E 2027 * | -12.9x |
|---|---|---|---|---|---|
| Enterprise Value | 5.73M 5.13M 4.74M 4.29M 8.02M 546M 8.15M 56.51M 22.55M 286M 21.51M 21.06M 905M | EV / Sales 2026 * |
1.57x | EV / Sales 2027 * | 0.37x |
| Free-Float |
77.92% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SCNX | Delayed | |
Tradegate
| 4E40 | Real-time | |
|
CBOE
| SCNX | Real-time | |
|
Deutsche Boerse AG
| 4E40 | Delayed |
Last Transcript: Scienture Holdings, Inc.
| 1 day | +2.65% | ||
| 1 week | +25.99% | ||
| Current month | -46.27% | ||
| 1 month | -47.64% | ||
| 3 months | -61.83% | ||
| 6 months | -62.48% | ||
| Current year | -72.63% |
| 1 week | 2.82 |  | 3.68 |
| 1 month | 2.64 | | 5.35 |
| Current year | 2.64 | | 16.11 |
| 1 year | 2.64 | | 27.75 |
| 3 years | 2.64 | | 335.5 |
| 5 years | 2.64 | | 335.5 |
| 10 years | 2.64 | | 335.5 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/19/24 | Conversion | Director | 2,927,538 | - | ||
| 9/19/24 | Conversion | Chief Executive Officer | 3,853,296 | - | ||
| 7/25/24 | Other | Director | 57,977 | 4.1225% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.65% | +25.99% | -84.70% | - | 5.73M | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | |
| +0.30% | +3.12% | +54.03% | +67.05% | 388B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | |
| +1.28% | +4.50% | +35.28% | +58.05% | 302B | |
| +4.72% | +6.33% | +8.69% | +33.45% | 271B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | |
| Average | +2.31% | +4.93% | +32.55% | +81.85% | 417.69B | |
| Weighted average by Cap. | +2.14% | +3.04% | +50.80% | +96.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.64M 3.26M 3.01M 2.72M 5.09M 347M 5.17M 35.89M 14.32M 181M 13.66M 13.37M 575M | 15.47M 13.86M 12.78M 11.57M 21.63M 1.47B 21.98M 153M 60.85M 771M 58.06M 56.82M 2.44B |
| Net income | -10.43M -9.34M -8.62M -7.8M -14.58M -993M -14.81M -103M -41.01M -520M -39.13M -38.29M -1.65B | -1.26M -1.13M -1.04M -944K -1.76M -120M -1.79M -12.44M -4.96M -62.9M -4.74M -4.64M -199M |
| Net Debt | - | - |
Employees
7
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | US$3.490 | +2.65% | 59,040 |
| 26-10-28 | US$3.400 | +5.26% | 41,965 |
| 26-10-27 | US$3.230 | +10.24% | 37,295 |
| 26-10-26 | US$2.930 | +1.74% | 16,857 |
| 26-10-23 | US$2.880 | +3.97% | 69,925 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.490USD
Average target price
6.000USD
Spread / Average Target
+71.92%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SCNX Stock
Select your edition
All financial news and data tailored to specific country editions
